table of content
1 Study Coverage
1.1 Oncology & Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology & Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology & Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology & Cancer Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Oncology & Cancer Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Oncology & Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oncology & Cancer Drugs Sales by Region
2.4.1 Global Oncology & Cancer Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Oncology & Cancer Drugs by Region (2023-2028)
2.5 Global Oncology & Cancer Drugs Revenue by Region
2.5.1 Global Oncology & Cancer Drugs Revenue by Region (2017-2022)
2.5.2 Global Oncology & Cancer Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oncology & Cancer Drugs Sales by Manufacturers
3.1.1 Global Top Oncology & Cancer Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Oncology & Cancer Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology & Cancer Drugs in 2021
3.2 Global Oncology & Cancer Drugs Revenue by Manufacturers
3.2.1 Global Oncology & Cancer Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Oncology & Cancer Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oncology & Cancer Drugs Revenue in 2021
3.3 Global Oncology & Cancer Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oncology & Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oncology & Cancer Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology & Cancer Drugs Sales by Type
4.1.1 Global Oncology & Cancer Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Oncology & Cancer Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Oncology & Cancer Drugs Sales Market Share by Type (2017-2028)
4.2 Global Oncology & Cancer Drugs Revenue by Type
4.2.1 Global Oncology & Cancer Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Oncology & Cancer Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oncology & Cancer Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Oncology & Cancer Drugs Price by Type
4.3.1 Global Oncology & Cancer Drugs Price by Type (2017-2022)
4.3.2 Global Oncology & Cancer Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oncology & Cancer Drugs Sales by Application
5.1.1 Global Oncology & Cancer Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Oncology & Cancer Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Oncology & Cancer Drugs Sales Market Share by Application (2017-2028)
5.2 Global Oncology & Cancer Drugs Revenue by Application
5.2.1 Global Oncology & Cancer Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Oncology & Cancer Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oncology & Cancer Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Oncology & Cancer Drugs Price by Application
5.3.1 Global Oncology & Cancer Drugs Price by Application (2017-2022)
5.3.2 Global Oncology & Cancer Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oncology & Cancer Drugs Market Size by Type
6.1.1 North America Oncology & Cancer Drugs Sales by Type (2017-2028)
6.1.2 North America Oncology & Cancer Drugs Revenue by Type (2017-2028)
6.2 North America Oncology & Cancer Drugs Market Size by Application
6.2.1 North America Oncology & Cancer Drugs Sales by Application (2017-2028)
6.2.2 North America Oncology & Cancer Drugs Revenue by Application (2017-2028)
6.3 North America Oncology & Cancer Drugs Market Size by Country
6.3.1 North America Oncology & Cancer Drugs Sales by Country (2017-2028)
6.3.2 North America Oncology & Cancer Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oncology & Cancer Drugs Market Size by Type
7.1.1 Europe Oncology & Cancer Drugs Sales by Type (2017-2028)
7.1.2 Europe Oncology & Cancer Drugs Revenue by Type (2017-2028)
7.2 Europe Oncology & Cancer Drugs Market Size by Application
7.2.1 Europe Oncology & Cancer Drugs Sales by Application (2017-2028)
7.2.2 Europe Oncology & Cancer Drugs Revenue by Application (2017-2028)
7.3 Europe Oncology & Cancer Drugs Market Size by Country
7.3.1 Europe Oncology & Cancer Drugs Sales by Country (2017-2028)
7.3.2 Europe Oncology & Cancer Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oncology & Cancer Drugs Market Size by Type
8.1.1 Asia Pacific Oncology & Cancer Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Oncology & Cancer Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Oncology & Cancer Drugs Market Size by Application
8.2.1 Asia Pacific Oncology & Cancer Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Oncology & Cancer Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Oncology & Cancer Drugs Market Size by Region
8.3.1 Asia Pacific Oncology & Cancer Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Oncology & Cancer Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oncology & Cancer Drugs Market Size by Type
9.1.1 Latin America Oncology & Cancer Drugs Sales by Type (2017-2028)
9.1.2 Latin America Oncology & Cancer Drugs Revenue by Type (2017-2028)
9.2 Latin America Oncology & Cancer Drugs Market Size by Application
9.2.1 Latin America Oncology & Cancer Drugs Sales by Application (2017-2028)
9.2.2 Latin America Oncology & Cancer Drugs Revenue by Application (2017-2028)
9.3 Latin America Oncology & Cancer Drugs Market Size by Country
9.3.1 Latin America Oncology & Cancer Drugs Sales by Country (2017-2028)
9.3.2 Latin America Oncology & Cancer Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oncology & Cancer Drugs Market Size by Type
10.1.1 Middle East and Africa Oncology & Cancer Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oncology & Cancer Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Oncology & Cancer Drugs Market Size by Application
10.2.1 Middle East and Africa Oncology & Cancer Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oncology & Cancer Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Oncology & Cancer Drugs Market Size by Country
10.3.1 Middle East and Africa Oncology & Cancer Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oncology & Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Celgene
11.2.1 Celgene Corporation Information
11.2.2 Celgene Overview
11.2.3 Celgene Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Celgene Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celgene Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Overview
11.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bristol-Myers Squibb Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Corporation Information
11.6.2 Merck & Co. Overview
11.6.3 Merck & Co. Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck & Co. Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck & Co. Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 AstraZeneca Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Amgen
11.9.1 Amgen Corporation Information
11.9.2 Amgen Overview
11.9.3 Amgen Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Amgen Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amgen Recent Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Corporation Information
11.10.2 Eli Lilly Overview
11.10.3 Eli Lilly Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Eli Lilly Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Eli Lilly Recent Developments
11.11 AbbVie
11.11.1 AbbVie Corporation Information
11.11.2 AbbVie Overview
11.11.3 AbbVie Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 AbbVie Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AbbVie Recent Developments
11.12 Takeda
11.12.1 Takeda Corporation Information
11.12.2 Takeda Overview
11.12.3 Takeda Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Takeda Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Takeda Recent Developments
11.13 Astellas
11.13.1 Astellas Corporation Information
11.13.2 Astellas Overview
11.13.3 Astellas Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Astellas Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Astellas Recent Developments
11.14 Ipsen
11.14.1 Ipsen Corporation Information
11.14.2 Ipsen Overview
11.14.3 Ipsen Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Ipsen Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ipsen Recent Developments
11.15 Sanofi
11.15.1 Sanofi Corporation Information
11.15.2 Sanofi Overview
11.15.3 Sanofi Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sanofi Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sanofi Recent Developments
11.16 Bayer
11.16.1 Bayer Corporation Information
11.16.2 Bayer Overview
11.16.3 Bayer Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Bayer Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Bayer Recent Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Corporation Information
11.17.2 Biogen Idec Overview
11.17.3 Biogen Idec Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Biogen Idec Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Biogen Idec Recent Developments
11.18 Teva
11.18.1 Teva Corporation Information
11.18.2 Teva Overview
11.18.3 Teva Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Teva Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Corporation Information
11.19.2 Otsuka Overview
11.19.3 Otsuka Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Otsuka Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Otsuka Recent Developments
11.20 Eisai
11.20.1 Eisai Corporation Information
11.20.2 Eisai Overview
11.20.3 Eisai Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Eisai Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Eisai Recent Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Corporation Information
11.21.2 Merck KGaA Overview
11.21.3 Merck KGaA Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Merck KGaA Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Merck KGaA Recent Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Corporation Information
11.22.2 Gilead Sciences Overview
11.22.3 Gilead Sciences Oncology & Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Gilead Sciences Oncology & Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Gilead Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology & Cancer Drugs Industry Chain Analysis
12.2 Oncology & Cancer Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology & Cancer Drugs Production Mode & Process
12.4 Oncology & Cancer Drugs Sales and Marketing
12.4.1 Oncology & Cancer Drugs Sales Channels
12.4.2 Oncology & Cancer Drugs Distributors
12.5 Oncology & Cancer Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oncology & Cancer Drugs Industry Trends
13.2 Oncology & Cancer Drugs Market Drivers
13.3 Oncology & Cancer Drugs Market Challenges
13.4 Oncology & Cancer Drugs Market Restraints
14 Key Findings in The Global Oncology & Cancer Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
